Published in Circ J on July 30, 2012
Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2. Cardiovasc Diabetol (2013) 0.97
Platelets in inflammation and atherogenesis. Front Immunol (2015) 0.94
Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function. Oxid Med Cell Longev (2014) 0.90
BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. EBioMedicine (2015) 0.88
High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation. PLoS One (2014) 0.84
Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. J Am Heart Assoc (2014) 0.84
Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages. Arterioscler Thromb Vasc Biol (2014) 0.83
Nox2 mediates high fat high sucrose diet-induced nitric oxide dysfunction and inflammation in aortic smooth muscle cells. J Mol Cell Cardiol (2014) 0.82
Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes. J Cell Mol Med (2014) 0.82
Prescribing optimal nutrition and physical activity as "first-line" interventions for best practice management of chronic low-grade inflammation associated with osteoarthritis: evidence synthesis. Arthritis (2012) 0.79
Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty. Heart Vessels (2013) 0.78
Small dense low density lipoprotein particles are associated with poor outcome after angioplasty in peripheral artery disease. PLoS One (2014) 0.78
Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18. Thromb Haemost (2015) 0.78
Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation. J Am Heart Assoc (2014) 0.77
Stimulatory interactions between human coronary smooth muscle cells and dendritic cells. PLoS One (2014) 0.76
Beyond Clotting: A Role of Platelets in CNS Repair? Front Cell Neurosci (2016) 0.75
Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase. J Mol Cell Cardiol (2016) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (1998) 8.92
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A (1990) 5.05
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature (1995) 4.84
The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol (2010) 4.26
Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol (1992) 3.94
Syk tyrosine kinase required for mouse viability and B-cell development. Nature (1995) 3.87
Transcription factors, normal myeloid development, and leukemia. Blood (1997) 3.71
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther (2006) 3.46
Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci U S A (1985) 3.41
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol (1993) 2.87
Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol (1997) 2.79
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 2.75
Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost (2001) 2.51
Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature (1992) 2.48
GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost (2005) 2.42
The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J (1997) 2.34
Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31
Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol (2002) 2.20
Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest (2000) 2.08
Molecular basis of restenosis and drug-eluting stents. Circulation (2005) 2.08
Transcriptional regulation of granulocyte and monocyte development. Oncogene (2002) 2.04
Morphological predictors of restenosis after coronary stenting in humans. Circulation (2002) 2.03
CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol (2002) 1.92
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
Inflammation and thrombosis: the clot thickens. Circulation (2001) 1.79
Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem (1996) 1.71
Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest (1997) 1.71
Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation (2005) 1.69
Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature (2000) 1.65
Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci (2004) 1.65
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem (1986) 1.62
Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol (1998) 1.55
A cascade model for restenosis. A special case of atherosclerosis progression. Circulation (1992) 1.53
Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol (1996) 1.53
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol (1991) 1.51
A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A (1998) 1.46
Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18). Proc Natl Acad Sci U S A (1994) 1.39
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation (1993) 1.36
Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest (2004) 1.34
Extracellular matrix changes in stented human coronary arteries. Circulation (2004) 1.32
Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J (1995) 1.32
Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood (2008) 1.31
In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res (1996) 1.19
Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol (1996) 1.19
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation (1996) 1.18
Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem (1994) 1.18
A MAC-1 attack: integrin functions directly challenged in knockout mice. J Clin Invest (1997) 1.17
Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest (1991) 1.16
Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation (2009) 1.15
Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. Proc Natl Acad Sci U S A (2004) 1.13
Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol (1994) 1.13
Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha. J Exp Med (2003) 1.12
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost (2009) 1.09
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood (2006) 1.07
Leukocyte integrin Mac-1 recruits toll/interleukin-1 receptor superfamily signaling intermediates to modulate NF-kappaB activity. Circ Res (2001) 1.06
Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol (1998) 1.04
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res (2002) 1.00
Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol (1996) 0.99
Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice. J Lipid Res (2000) 0.98
Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1996) 0.96
Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation (2001) 0.96
Alpha4beta1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice. J Vasc Res (2004) 0.92
Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation (2001) 0.90
Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. Circulation (1995) 0.90
Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med (2003) 0.90
Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases. Arthritis Res Ther (2010) 0.88
Critical role for Syk in responses to vascular injury. Blood (2011) 0.88
Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. Am J Physiol Cell Physiol (2006) 0.86
Chemokines on the rise : mcp-1 and restenosis. Arterioscler Thromb Vasc Biol (2001) 0.80